Cargando…

Use of proton pump inhibitors for the risk of gastric cancer

This study aimed to systematically analyze the association between long-term use of proton pump inhibitors (PPIs) and the risk of gastric cancer (GC). METHODS: We performed a systematic search of articles on the relationship between long-term use of PPIs and the risk of GC from PubMed and EMBASE. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Huiqin, Li, Lunan, Geng, Ke, Teng, Changzheng, Chen, Yuanyuan, Chu, Fei, Zhao, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750528/ https://www.ncbi.nlm.nih.gov/pubmed/36626449 http://dx.doi.org/10.1097/MD.0000000000032228

Ejemplares similares

Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Celiac disease serology and gut microbiome following proton pump inhibitor treatment
por: Jang, Sophie, et al.
Publicado: (2020)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up
por: He, Suyu, et al.
Publicado: (2020)

Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis
por: Cheng, Tao, et al.
Publicado: (2021)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation: A Retrospective Cohort Study
por: Kang, Seong Hee, et al.
Publicado: (2016)

Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study
por: Hsieh, Hui-Hsia, et al.
Publicado: (2021)

Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors
por: Jiang, Liuqin, et al.
Publicado: (2016)

Whether long-term use of proton pump inhibitor increases the risk of precancerous lesions in the stomach: A systematic review and meta-analysis of randomized controlled trials
por: Lv, Fangyi, et al.
Publicado: (2023)

A review of the long-term use of proton pump inhibitors and risk of celiac disease in the context of HLA-DQ2 and HLA-DQ8 genetic predisposition
por: McMillan, Alexandra, et al.
Publicado: (2023)

Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis
por: Li, Mei-Juan, et al.
Publicado: (2017)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies
por: Martin,, et al.
Publicado: (2020)

Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis
por: Yang, Sensen, et al.
Publicado: (2022)

Risk Factors of Submucosal or Lymphovascular Invasion in Early Gastric Cancer <2 cm
por: Choi, Yu Yi, et al.
Publicado: (2016)

Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients
por: Paik, Kyu-hyun, et al.
Publicado: (2016)

Training in Early Gastric Cancer Diagnosis Improves the Detection Rate of Early Gastric Cancer: An Observational Study in China
por: Zhang, Qiang, et al.
Publicado: (2015)

Predictive risk factors associated with synchronous multiple early gastric cancer
por: Jeong, Seok Hoo, et al.
Publicado: (2017)

Evaluation of multiple biological indicators for combined diagnosis of gastric cancer: A retrospective analysis
por: Zhao, Qinfu, et al.
Publicado: (2022)

MECP2 expression in gastric cancer and its correlation with clinical pathological parameters
por: Zhang, Jing, et al.
Publicado: (2017)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Risk of Spontaneous Bacterial Peritonitis Associated With Gastric Acid Suppression
por: Chang, Shy-Shin, et al.
Publicado: (2015)

Association of Genetic Variants in and Promoter Hypermethylation of CDH1 With Gastric Cancer: A Meta-Analysis
por: Jing, Huiquan, et al.
Publicado: (2014)

Risk factors and a simple model for predicting bile leakage after radical hepatectomy in patients with hepatic alveolar echinococcosis
por: Yang, Xianwei, et al.
Publicado: (2017)

Risk factors for lymph node metastasis of early gastric cancers in patients younger than 40
por: Ji, Tao, et al.
Publicado: (2017)

Application effect of gastrointestinal bundle nursing on the protection of gastrointestinal function in patients with gastric cancer
por: Wei, Xiao-Ning, et al.
Publicado: (2023)

Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: An individualized consideration of the risk factors
por: Park, Yoo Mi, et al.
Publicado: (2016)

Association of APC gene promoter methylation and the risk of gastric cancer: A meta-analysis and bioinformatics study
por: Zhou, Xueliang, et al.
Publicado: (2020)

Risk factors and clinical outcomes of postgastrectomy sarcopenia newly developed after curative resection for gastric cancer
por: Kim, Hye Jin, et al.
Publicado: (2022)

The association between polymorphism of the long noncoding RNA, Plasmacytoma variant translocation 1, and the risk of gastric cancer
por: Park, Jae Ho, et al.
Publicado: (2021)

Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study
por: Oh, Mi Jin, et al.
Publicado: (2023)

Analysis of clinicopathologic characteristics and prognosis of gastric cancer in patients <40 years
por: Liu, Lifeng, et al.
Publicado: (2023)

The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report
por: Xia, Jie, et al.
Publicado: (2018)

Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section
por: Zhang, Wei, et al.
Publicado: (2017)

Value of Magnifying Endoscopy With Narrow-Band Imaging and Confocal Laser Endomicroscopy in Detecting Gastric Cancerous Lesions
por: Gong, Shuai, et al.
Publicado: (2015)

The significance of endoscopic Kyoto classification of gastritis in the gastric cancer risk assessment: A systematic review and meta‑analysis
por: Zhang, Hangbin, et al.
Publicado: (2023)

High risk factors related to lymph node metastasis in early gastric cancer: A retrospective observational study
por: Fan, Xiaoyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4no6q1qhco1slnvo7r5ced88vo